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The contribution of preclinical MRI in advancing 3R efforts 
in the life sciences is undoubtedly a hot area of discussion. 
For this reason, the 2nd ESMRMB preclinical MRI day 
“Frontiers in Preclinical MRI” on September 30, 2020 was 
included in the program of the online Annual Meeting of the 
ESMRMB and was focused on animal welfare. A dedicated 
two-hour session: “Living up to the 3R principle—Contribu-
tion of preclinical MRI” provided the forum for discussion 
about contributions of preclinical MRI to the 3R efforts in 
the life sciences. After setting the stage with a 30-min intro-
ductory lecture about the 3R principle by Armand Mensen 
from the Swiss 3R Competence Centre, nine selected con-
tributions that were received in response to a Europe-wide 
call on the topic, provided insight into capabilities of MRI, 
its current use and shortcomings that must be addressed in 
the future.
General considerations on ethics 
in experimental animal research
In 1959, William Russel and Rex Burch [1] proposed that in 
the interest of laboratory animal welfare, scientists should 
adhere to the recommendations of the 3Rs: replacement, 
reduction, refinement. This topic was elaborated upon dur-
ing the introductory lecture. Since Russell and Burch, 3R 
recommendations have evolved into requirements and ani-
mal welfare legislation that are imposed upon the researcher. 
Accordingly, the most referenced EU Directive (Directive 
2010/63/EU on the protection of animals used for scientific 
purposes) states that animals have intrinsic value that needs 
to be respected. Animal welfare considerations should be 
given the highest priority as per the directive, and each use 
needs to be carefully evaluated. All in all, the 3Rs should be 
considered systematically when using animals in biomedi-
cal research.
Replacement stands for making sure that research ques-
tions cannot be answered by alternative approaches using 
material from non-living animals, such as cell culture, 3D 
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organoids, or multiple organ systems; or that animal experi-
ments cannot be replaced by developing computational 
models. Furthermore, successful replacement can also be 
accomplished when using creatures considered to be less 
prone to the consequences of suffering (based on the phy-
logenetic hierarchy). Such creatures should be selected 
for experiments (e.g. invertebrates instead of vertebrates) 
whenever appropriate to the experimental goals. Reduction 
is the R where non-invasive imaging excels best due to the 
stark reduction in required animal numbers. With longitu-
dinal monitoring, comparable levels of information can be 
retrieved from fewer animals. Progression of disease or treat-
ment response can be tracked, statistical power is increased, 
and individual trait differences (for example early versus 
late responders) can be identified. Non-invasive imaging 
also allows the retrieval of more information from the same 
number of animals. Preclinical MRI offers multiple tech-
niques to assess numerous outcome measures within one 
MRI session. Additionally, MRI may be complemented by 
further non-invasive imaging techniques (e.g. PET or opti-
cal imaging) and by behavioral and clinical examinations. 
Armand Mensen extended the general narrow focus of the 
reduction principle introducing concepts which improve 
experimental design by considering for example sex bias 
and standardization fallacy [2, 3]. Refinement of experimen-
tal techniques to minimize or alleviate pain, suffering and 
distress not only serves animal welfare but also improves 
science considerably. Environmental enrichment has a posi-
tive impact on animal stress, anxiety and behavior as well as 
scientific results. Reducing unnecessary stressors can lead to 
more reliable and robust results [4]. Impressive in this regard 
is research on the impact of non-aversive handling [5, 6].
The 3R principle now refers to far more than each of the 
Rs mere classical definition. In addition to ethical aspects, 
the scientific value of research with animal welfare meas-
ures is of utmost importance. In a recent publication, Strech 
and Dirnagl [7] proposed to complement the ethical 3Rs 
with a set of measures assuring scientific quality of animal 
experiments, namely robustness, registration and reporting 
(Fig. 1). These additional principles demand sample size 
calculations and blinding to enhance the validity and reli-
ability of results. Pre-registration of working hypotheses and 
experimental designs in public registries [8] together with 
extensive reporting (for example according to the Animal 
Research: Reporting of In Vivo Experiments (ARRIVE) 
guidelines [9]) are suggested to increase transparency and 
reproducibility and to justify the relevance of the proposed 
experiments.
Contributions of preclinical MRI to the 3Rs
Following the introductory lecture, nine presentations illus-
trated exemplary applications of MRI in preclinical studies 
in the context of the 3R principle. Given the non-invasive-
ness of MRI and the option to perform longitudinal studies, 
several examples highlighted the contribution of preclinical 
MRI to reduce animal numbers.
Cristina Barca et al. presented a longitudinal, multimodal 
imaging study in a mouse stroke model [10]. T2-weighted 
anatomical MRI was combined with diffusion-weighted 
MRI and arterial spin labeling MRI to assess brain perfu-
sion. At alternating time points, MRI was complemented by 
DPA PET to measure inflammation. By repeated examina-
tions in individual mice, animal numbers could be reduced 
from 96 to 16 in this study.
Marlene Wiart et al. shared data from another preclinical 
stroke trial in rats that evaluated the neuroprotective effects 
of remote ischemic conditioning [11]. The primary endpoint 
was edema-corrected lesion size measured by T2-weighted 
MRI at 24 h of reperfusion normalized by the area-at-risk 
of infarction determined from per-occlusion MRI for each 
individual. Of note, with T2-weighted anatomical MRI 
lesion size was more sensitively detected compared to TTC 
(2,3,5-triphenyltetrazolium chloride) staining of fresh brain 
tissues, the gold standard of reference for evaluation of 
infarct size in conventional experimental animal studies. 
Sample size calculations based on the effect sizes in this 
study revealed 19 instead of 55 animals per group when 
planning a longitudinal MRI study instead of using TTC 
staining of fresh brain tissues, the gold standard for evalua-
tion of infarct size in conventional experimental rodent stud-
ies. Including the 40% exclusion rate (due to mortality but 
also to the strict inclusion of animals that have effectively 
experienced brain ischemia as documented by per-occlusion 
MRI) this resulted in 64 versus 184 surgeries, or 120 spared 
animals. The fact that in the clinical setting lesion size is 
usually determined by MRI highlights the outstanding trans-
lational value of MRI-based diagnostic endpoints in preclini-
cal stroke studies.
Fig. 1  Two basic principles for 
experimental animal research 
translate into six practice-guid-
ing principles (6R). [Modified 
from [7]]
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Catarina Tristão-Pereira et al. presented a longitudinal 
multimodal imaging study combining resting-state fMRI, 
diffusion-weighted MRI and FDG-PET in a rat model of 
Alzheimer’s disease. The pathology of progressive neuro-
degeneration induced by brain glucose metabolism disrup-
tion in this animal model (effectively “type 3 diabetes”) had 
previously only been characterized at different timepoints 
using histology [12], thus recruiting a larger number of ani-
mals while not benefiting from a truly longitudinal—but 
rather cross-sectional—analysis. Here, animal numbers were 
reduced by a factor of three and the study reported a non-
monotonic trend in white matter degeneration and changes 
in resting-state functional connectivity characterized by an 
early acute decline, temporary recovery and finally chronic 
degeneration [13] which preceded a similar trend at the 
behavioral level [12]. Combination of several complemen-
tary imaging methodologies at the same time increased the 
scientific value of the study. Furthermore, the resting-state 
fMRI and anatomical MRI data are publicly available for 
reuse: https:// openn euro. org/ datas ets/ ds003 520. The use of 
medetomidine over alpha-chloralose for the fMRI studies 
also decreased animal count.
Alice Busato et al. presented a MRI investigation of their 
transgenic mouse model of pancreatic cancer (KPC). High-
resolution T2-weighted images were acquired longitudinally, 
starting from 3-month-old mice, every 10 days, until the 
humane endpoint. MRI was able to follow the evolution of 
the four-class imaging-based tumor staging, detecting the 
first stage of the tumor as multiple liquid cysts inside pan-
creas (hyper-intense alterations), and its evolution toward a 
solid mass in a single subject. Due to the longitudinal study 
design, animal numbers were substantially reduced. Moreo-
ver, at the last stage of the pathology, MRI allowed detection 
of metastasis in the abdominal region.
All 3R principles, replacement, reduction and refinement, 
were met in a study by Liesbeth Vanherp et al. in a murine 
model of cerebral Cryptococcus neoformans infections. 
Typically, virulence is studied by infecting large groups 
of animals and recording survival or analyzing fungal bur-
den of the infected organs ex vivo, which does not provide 
insights in how disease establishes and progresses. With 
MRI, already disease onset was indicated by enlargement of 
ventricles, edema, hydrocephalus, presence of parenchymal 
lesions, and fluid accumulation around major vasculature 
and the meninges. Even when survival rates were similar, 
the relative contributions of these different parameters were 
highly variable between strains, but not between animals 
infected with the same strain. By assessing animals repeat-
edly (up to seven times) over a period of up to 39 days after 
infection, this MRI-based in vivo virulence study reduced 
animal numbers by at least a factor of six when compared 
to an exclusively histology-based approach. By providing 
early virulence markers, preclinical MRI could replace pure 
survival rate studies. Refinement could also be addressed, 
because burden of the animals would substantially be 
reduced by sacrificing them before severe symptoms cause 
their death.
Pathological observations in animal models of disease 
are of little consequence if they do not reflect the human 
counterpart. Millward et al. observed dynamic expansions 
and contractions of ventricle volumes in the mouse model 
of multiple sclerosis (experimental autoimmune encepha-
lomyelitis) by repeated MR measurements over a 2-month 
period [14]. In Multiple Sclerosis (MS) patients, short-term 
fluctuations in ventricle volumes were less striking than 
those in the animal model but they were clearly present. 
Interestingly, MS patients showing expansions and contrac-
tions beyond the normal range of variation were at an earlier 
disease stage. This suggests that fluctuations are indicative 
of inflammatory activity. The preclinical study facilitated a 
significant reduction in animal numbers. Pathological obser-
vations were relevant to MS patients and could be of future 
benefit in the diagnosis and monitoring of MS patients.
In summary, these examples showed that considerable 
reductions in animal numbers were accomplished by repeat-
edly imaging animals during the course of the experiment, 
instead of running verum and control groups for each time 
point. This allowed for investigating dynamic processes, 
like disease progression or treatment response. Each ani-
mal served as its own control/baseline and trait differences 
could be tracked individually. Statistical power was higher 
compared to inter-individual comparisons. Integrating multi-
ple imaging modalities (for example different MRI methods 
and/or PET) and complementing study design by behavioral 
measures, clinical examinations and histological validation 
increased the scientific value of these studies. Translational 
value in particular of MRI endpoints was high.
Two further contributions showed examples where MRI 
contributed to the 3R principle of replacement.
Gordon Winter et al. introduced the use of hen’s egg test 
chorioallantoic membrane model (HET-CAM) in MRI for 
in vivo testing of novel target-specific radioligands [15]. 
Multi-modal PET and MR imaging of hen’s eggs before 
embryo development day 20 represent an alternative to 
established small animal models for biodistribution assess-
ment. Only successful candidates then proceed to further 
testing for example in the severe combined immuno-defi-
cient (SCID) mouse model.
Millward et al. shared their method for preparing fixed 
rodent phantoms for ex vivo MR imaging [16]. Such phan-
toms preserve the internal anatomy in situ. They are useful 
for introducing trainees into pre-clinical MRI of various tar-
get organs, without the need for living animals. The phan-
toms can be conveniently stored and re-used, reducing the 
total number of animals needed. The phantoms are particu-
larly useful for developing and refining new MRI methods, 
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thus improving the reliability and reproducibility of subse-
quent imaging experiments with living animals.
Finally, with “OpenMind”—The Open Database of 
Anesthetic Effects and Protocols for Preclinical Research 
Henning M. Reimann et al. presented an example on how 
MRI complies with the extended 3R principles. Rodent 
functional magnetic resonance imaging (fMRI) can replace 
more invasive readouts for assessing brain activity. However, 
the necessity to anesthetize animals during examination has 
a prominent impact on study outcome and comparability 
with human studies. A recent publication by the group [17] 
outlined that anesthesia affects overall physiology, including 
brain states, functional networks, information transfer, sen-
sory processing and hemodynamic integrity—i.e., the physi-
ological translation of neuronal activity into hemodynamic 
responses captured by fMRI. Thereby, different anesthetics 
affect the above measures in distinct ways, which pose a 
further challenge for data interpretation. An open encyclo-
pedia for anesthetic effects is proposed as platform to report 
and share findings and data with the community. The goal 
is to provide a powerful web-based infrastructure for fast 
and easy dissemination of findings, data, and protocols to 
gain a better understanding of anesthetic effects. This will 
help to establish optimized anesthetic protocols and define 
robust experimental conditions for functional neuroimag-
ing studies, and in turn foster scientific quality and reduce 
animal numbers.
While there is always more to be done, the interactive 
panel and attendees agreed that preclinical MRI indeed is 
living up to the 3R principle. Foremost, the aspect of reduc-
tion is addressed by the possibility to perform longitudinal 
studies allowing precise monitoring of disease progression 
and response to therapy in models of different diseases. Bio-
logical variability can be alleviated, as each animal serves 
as its own control. Added scientific value is provided by 
simultaneously acquiring molecular, functional, metabolic 
and anatomical information and by the combination of com-
plementary non-invasive imaging modalities. Such combi-
nations are feasible, since the Directive 2010/63/EU states 
only minor burden experienced by the animals, mostly due 
to the impact of anesthesia (length of examination times 
and number of repeated anesthetic interventions). However, 
multiple longitudinal measures of an animal can act as an 
additional stressor in and of itself as it involves an increase 
in experimenter handling. However, these can be mitigated 
using appropriate refinement techniques, such as tunnel han-
dling and environmental enrichment approaches. Its non-
invasiveness makes preclinical MRI a possible alternative 
to replace conventional, invasive experimental techniques. 
The fact that MRI is the established diagnostic method in 
the clinical setting for many diseases adds high translational 
value. However, MRI needs to mature to a “gold standard” 
for outcome parameters.
Steps to be taken to exploit the full potential 
of MRI with regards to the 3R principle
The general appraisal of the attendees of this session was 
that within the imaging community there is little doubt about 
the merit of MRI in experimental preclinical research, but 
its potential is not yet fully tapped. Within the framework of 
the 3Rs (Fig. 2), preclinical MRI contributes to Reduction of 
animal numbers and allows for Refinement or even Replace-
ment of more invasive experimental techniques. However, 
MRI metrics alone are often not considered sufficient by 
reviewers and funding agencies, and more invasive experi-
ments are frequently requested.
What can be done to raise the awareness of the value of 
MRI and to establish it as reference standard? Obviously, 
Fig. 2  Preclinical MRI within 
the framework of the 3R 
principle
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systematic validation studies are needed to accredit valid-
ity and to convince the scientific community that MRI-
based endpoints often outperform conventional, invasive 
outcome measures, as shown by examples of determin-
ing lesion size in stroke models or tumor volume in solid 
cancer imaging. In particular, MRI measures win over as 
early disease marker for many applications. Adhering to 
the extended 3R guidelines, Robustness, Registration and 
Reporting will further strengthen the scientific value and 
enhance acceptance of preclinical MRI. Other important 
initiatives in this regard are efforts to implement standard-
ized animal imaging protocols, for example for whole-
brain fMRI [18]. However, even if the added value of 
preclinical MRI has been widely accepted, it is often not 
employed as tool to provide valid data, but only repre-
sents the cherry on the methodological cake. One reason 
why non-invasive imaging still has not yet become a rou-
tine application may be the location and infrastructure of 
most imaging facilities (availability of the MRI systems, 
cost of MR sessions). Substantial regulatory work is often 
required before animals can be transferred to an imaging 
facility. Hygiene requirements may prohibit that animals 
leave the imaging facility once they have entered it, and 
additional experimental options, such as behavioral test-
ing or surgical intervention, may not be available in the 
imaging facilities. To exploit the potential of performing 
longitudinal studies, sufficient animal housing options 
and room for performing complementary experimental 
procedures should be integrated within imaging facilities 
whenever possible.
Efforts by the whole preclinical imaging community 
are required to promote MRI and other non-invasive imag-
ing methods. Leaving the comfort zone of discussing pre-
clinical MRI studies within the imaging community, and 
advocating imaging studies more proactively in front of 
clinicians and disease-oriented biomedical research com-
munities will help to promote preclinical MRI.
Further measures include engaging in work with the 
animal welfare authorities, especially in local commis-
sions where individual experiment licenses are discussed. 
Also getting involved in animal welfare training within the 
scope of Federation of European Laboratory Animal Sci-
ence Associations (FELASA) may raise the community’s 
recognition of the value of non-invasive preclinical MRI 
and promote its routine application in experimental animal 
research in line with the 3R principle.
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